Have you taken the drug atezolizumab (also known as Tecentriq) in combination with nab-paclitaxel for locally advanced or secondary triple negative breast cancer?
You could help shape our input to the Scottish Medicines Consortium (SMC) assessment that will decide whether this treatment is made available on the NHS in Scotland.
We want to hear from people that have received this drug combination to help shape what we say to the SMC about this treatment.
If you can help please get in touch and tell us your story by 13 March at breastcancernow.org/about-us/tell-us-your-story